Roche · 21 hours ago
2026 Summer Intern - Translational Medicine
Roche is a leading biotechnology company focused on transforming patient care. The internship in Translational Medicine involves generating cancer organoid models, conducting translational research, and supporting oncology projects through innovative scientific strategies.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Generate genetically defined murine lung cancer organoid models using CRISPR-based genome editing
Culture and maintain mouse tracheal epithelial organoids for cancer modeling
Engineer and validate key cancer-associated genetic alterations relevant to lung squamous cell carcinoma
Use human cancer genomics insights to guide model design and hypothesis generation
Perform molecular and phenotypic characterization of engineered organoids
Analyze data and communicate results to support translational oncology research
Qualification
Required
Must be pursuing a PhD (enrolled student)
Required majors: Cancer biology, Molecular biology, Immunology or related disciplines
Preferred
Familiarity with CRISPR/Cas9 genome editing and murine organoid culture systems is a plus
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-09
2026-01-07
Company data provided by crunchbase